Versor Investments LP bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,920 shares of the company’s stock, valued at approximately $1,184,000.
A number of other hedge funds also recently made changes to their positions in HQY. Sivia Capital Partners LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at $306,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of HealthEquity during the 2nd quarter valued at $4,747,000. Marshall Wace LLP acquired a new position in shares of HealthEquity during the 2nd quarter valued at $5,483,000. Amundi lifted its holdings in shares of HealthEquity by 9.3% during the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC acquired a new position in shares of HealthEquity during the 2nd quarter valued at $449,000. Institutional investors and hedge funds own 99.55% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on HQY. Raymond James Financial set a $100.00 target price on shares of HealthEquity in a report on Tuesday, February 17th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Royal Bank Of Canada reduced their target price on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating on the stock in a report on Wednesday, March 18th. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Finally, BTIG Research reduced their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $111.79.
HealthEquity Stock Performance
HealthEquity stock opened at $80.46 on Wednesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a market capitalization of $6.80 billion, a price-to-earnings ratio of 32.71, a price-to-earnings-growth ratio of 1.48 and a beta of 0.19. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. The firm’s fifty day moving average price is $81.65 and its 200 day moving average price is $87.52.
HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. On average, research analysts forecast that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
